1
Microdose Buprenorphine Initiation for Opioid Use Disorder
Condition(s):Opioid Use DisorderLast Updated:September 13, 2023Not yet recruiting
Buprenorphine: 784 Clinical Trials, Page 1 of 79
Hide Studies Not Open or Pending
2
Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
Condition(s):Neonatal Abstinence Syndrome; Neonatal Opiate Withdrawal SyndromeLast Updated:February 11, 2022Completed
3
New Application of Buprenorphine Patch on Painful Knee Joint in Knee Osteoarthritis Patients
Condition(s):Knee OsteoarthritisLast Updated:May 13, 2019Unknown status
4
Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women
Condition(s):Opioid Use DisorderLast Updated:October 14, 2020Withdrawn
5
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
Condition(s):Opioid-use DisorderLast Updated:May 11, 2023Recruiting
6
An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
Condition(s):Opioid-use DisorderLast Updated:March 9, 2021Completed
7
SUBLOCADE Rapid Initiation Study
Condition(s):Opioid-use DisorderLast Updated:October 3, 2022Completed
8
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
Condition(s):Opioid-use DisorderLast Updated:March 24, 2020Withdrawn
9
Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
Condition(s):Sickle Cell DiseaseLast Updated:April 25, 2022Completed
10
Buprenorphine for Cancer Pain
Condition(s):Cancer-Related PainLast Updated:July 10, 2023Recruiting